Trials / Unknown
UnknownNCT03642405
Drug-induced Repolarization ECG Changes
Exploring the Effect of Methylphenidate and Antidepressants on Cardiac Repolarisation.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Copenhagen University Hospital at Herlev · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Studies have shown that the risk of developing heart arrhythmias, is increased in patients receiving medication for Attention-deficit hyperactivity disorder (ADHD) and depression. The QT-interval on a electrocardiogram (ECG) is often used to assess the patients risk of developing heart arrhythmias. The QT-interval defines the hearts electrical resting period and a long interval is linked to an increased risk of developing heart arrhythmias. In this project the investigators wish to examine possible side-effects in patients receiving medication for ADHD and depression and their dynamic QT-interval changes, by analysing the ECG changes that occur during "Brisk Standing".
Conditions
- Long QT Syndrome
- ADHD
- Depression
- Death
- Death, Sudden, Cardiac
- Romano-Ward Syndrome
- Pathologic Processes
- Heart Arrest
- Electrocardiogram: Electrical Alternans
- Heart Diseases
- Cardiovascular Diseases
- Death, Sudden
- Arrhythmias, Cardiac
- Heart Defects, Congenital
- Cardiovascular Abnormalities
- Congenital Abnormalities
- Genetic Disease
- Genetic Syndrome
- Qt Interval, Variation in
- Psychiatric Disorder
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Electrocardiogram examination | 12-lead ECG monitored by Holter |
| DIAGNOSTIC_TEST | Echocardiography | Echocardiography in accordance to Danish Society of Cardiology |
| PROCEDURE | Blood Samples | Blood Samples include, Genetic analysis, serum-Methylphenidate, serum-Citalopram. Sodium, Potassium, Magnesium, Calcium, Chloride, White-Blood-Count, Hemoglobin, C-reactive-Protein, Creatinine, Carbamide, aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), Glucose and pro-brain natriuretic peptide (Pro-BNP). |
| BEHAVIORAL | Questionnaire | Questionnaire regarding patients quality of life |
Timeline
- Start date
- 2018-08-15
- Primary completion
- 2019-09-03
- Completion
- 2022-01-01
- First posted
- 2018-08-22
- Last updated
- 2019-01-03
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03642405. Inclusion in this directory is not an endorsement.